| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.48B | $1.31B | $1.66B |
| YoY Revenue Growth % | +13.0% | -21.1% | — |
| Gross Profit | $462.4M | $435.9M | — |
| Gross Margin % | 31.2% | 33.2% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $35.5M | $50.5M | $250.6M |
| Operating Margin % | 2.4% | 3.8% | 15.1% |
| Net Income (GAAP) | $66.1M | $44.0M | $227.2M |
| EBITDA (Normalized) | $98.2M | $108.9M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $215.5M | $119.4M | $280.9M |
| Capital Expenditures (CapEx) | $78.4M | $73.0M | — |
| Free Cash Flow (FCF) | $137.2M | $46.4M | $280.9M |
| FCF Margin % | 9.3% | 3.5% | 16.9% |
| Return on Invested Capital (ROIC %) | 1.9% | 2.7% | — |
| Cash & Short-Term Equivalents | $367.2M | $308.7M | — |
| Total Debt (Short + Long Term) | — | — | — |
| Total Stockholders' Equity | $1.88B | $1.80B | — |